Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)

Completed

Conditions studied: Edematous Fibrosclerotic Panniculopathy

In brief

This study will evaluate the long-term safety and duration of efficacy of CCH in the treatment of women with cellulite. This study will be a single day evaluation, approximately 48 months after the first dose of study drug was received in the EN3835-201.

Key facts

Study ID
NCT04381117
Run by
Endo USA Inc., a Keenova Therapeutics Company
People needed
7
Starts
2020-05-06
Expected to finish
2020-06-22
Last updated by the study team
2024-01-02

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.